Autumn Schierling plays on the playground at The Children’s Inn at NIH in Bethesda on Tuesday. (Marvin Joseph/The Post)

Perspective

The 10-year-old, who was born with NF1, has been participating in a trial at NIH that recently resulted in the first approval of a treatment.